Jazz Pharmaceuticals: Truist Securities keeps Buy rating, raises PT to $230.

lunes, 12 de enero de 2026, 11:46 am ET1 min de lectura
JAZZ--

Jazz Pharmaceuticals: Truist Securities keeps Buy rating, raises PT to $230.

Jazz Pharmaceuticals: Truist Securities keeps Buy rating, raises PT to $230.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios